Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance January 31, 2017
The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016 January 25, 2017
The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Barrett & Griffiths (2016) January 25, 2017
The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Barrett & Griffiths (2016) January 25, 2017
Psilocybin: promising results in double-blind trials require confirmation by real-world evidence December 6, 2016
